CAS 1612755-71-1

PF-06260414

CAS : 1612755-71-1

PF-06260414 is a potent and selective inhibitor of the enzyme 11β-HSD1. It has been shown to increase testosterone levels in men with hypogonadism and may have a beneficial effect on muscle mass and body composition. PF-06260414 is also an inhibitor of the matrix metalloproteinases (MMPs) that are involved in cancer metastasis, suggesting that it may be effective against cancer. This drug has not yet been studied in human clinical trials. PF-06260414 is currently being investigated for its potential use as a treatment for cachexia, which is a condition characterized by weight loss caused by chronic diseases. The compound has been shown to reduce appetite and food intake in animals, suggesting that it may also have potential as an anti-obesity drug.

Formule : C₁₄H₁₄N₄O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 302.35 g/mol

Ref: 3D-MPC75571

PF-06260414

CAS : 1612755-71-1

PF-06260414 is a selective androgen receptor modulator or SARM used to treat muscle weakness.

Formule : C₁₄H₁₄N₄O₂S

Couleur et forme : Solid

Masse moléculaire : 302.35

Ref: TM-T33944